INmune Bio
INMB
13 hedge funds and large institutions have $1.14M invested in INmune Bio in 2020 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 1 closing their positions.
500% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 1
300% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 1
18% more funds holding
Funds holding: 11 → 13 (+2)
0.58% more ownership
Funds ownership: 2.62% → 3.2% (+0.58%)
30% less capital invested
Capital invested by funds: $1.64M → $1.14M (-$496K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FAIM
Financial Advocates Investment Management
Olympia,
Washington
|
+$130K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$51.7K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$45.2K |
| 4 |
BlackRock
New York
|
+$41.6K |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$6.59K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
-$3K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$14 |
INMB Hedge Fund Activity: Q1 2020 in Review
13 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in INmune Bio (INMB) for Q1 2020, worth a combined $1.14M — down 30% from $1.64M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new INMB positions and 1 closed out — a net gain of 5 holders — while 4 added to existing stakes and 1 trimmed.
The largest buyer was Financial Advocates Investment Management, adding an estimated $130K. The largest seller was Advisory Services Network, exiting entirely with an estimated $3K sold.
- 13 institutional investors held INmune Bio (INMB) as of Q1 2020, up from 11 in Q4 2019.
- Funds reported $1.14M of INmune Bio stock for Q1 2020, down 30% quarter-over-quarter.
- 6 funds opened new INmune Bio positions in Q1 2020 and 1 closed out, a net change of +5 holders.
- The largest INmune Bio buyer in Q1 2020 was Financial Advocates Investment Management, an estimated $130K added.
- The largest INmune Bio seller in Q1 2020 was Advisory Services Network, an estimated $3K sold.
Based on aggregated 13F filings for Q1 2020.